NeuroOne Medical Technologies Corporation Common Stock (NMTC) Stock Price
NMTCStock
$0.96−81.44%52W
Market Cap$8.75M
P/E—
PEG Ratio—
Div yield—
Beta0.92
NMTC Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-87.96%
Price vs S&P 500 (4W)-24.72%
VGM Score47.06
NMTC Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.22 | -$0.28 | -29.23%(-$0.06) | |
| Q4 2025 | -$0.24 | -$0.18 | +25.00%(+$0.06) | |
| Q3 2025 | -$0.24 | -$0.24 | +0.00%(+$0.00) | |
| Q2 2025 | -$0.30 | -$0.18 | +40.00%(+$0.12) |
NMTC Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.22
4.22
4.22
4.22
Industry Peers — Surgical & Medical Instruments(142)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
NMTCNeuroOne Medical Technologies Corporation Common Stock | B | B | F | 0.9x | 44.4% | 55.7% | -76.0% | $0.96 |
| SYKStryker Corporation | C | B | C | 4.4x | 11.8% | 65.3% | 21.3% | $294.66 |
| MMM3M Company | C | D | B | 3.4x | -5.0% | 39.4% | 18.4% | $164.75 |
| BSXBoston Scientific Corp. | C | B | C | 3.1x | 15.2% | 69.5% | 19.8% | $44.39 |
| BDXBecton, Dickinson and Co. | B | D | A | 2.5x | 6.3% | 46.7% | 9.6% | $191.75 |
| MDLNMedline Inc. Class A common stock | C | D | C | 1.6x | — | 26.2% | 6.0% | $35.96 |
| RMDResMed Inc. | C | C | B | 5.9x | 12.1% | 61.1% | 33.4% | $238.97 |
| DXCMDexCom, Inc. | C | B | B | 6.5x | 19.3% | 64.3% | 22.9% | $86.04 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | 8.5x | 7.4% | 36.8% | 20.4% | $384.02 |
| SOLVSolventum Corporation | C | C | B | 1.8x | — | 54.8% | 23.9% | $85.81 |
| BAXBaxter International Inc. | B | D | B | 1.1x | -0.8% | 30.7% | -2.3% | $25.28 |
About NeuroOne Medical Technologies Corporation Common Stock
NeuroOne Medical Technologies develops thin film electrode technology for diagnostic, therapeutic, and monitoring applications in neurology, focusing on epilepsy, Parkinson's disease, and pain management. The company commercializes products including the Evo Cortical, Evo sEEG, and OneRF Ablation System for brain recording, stimulation, and ablation.